VCYT · Veracyte, Inc. · Executive Compensation

$40.87 -1.16 (-2.76%) At close · Sep 11

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$3.29B

80.39M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marc Stapley	Chief Executive Officer	$700,000	—	$5,890,877	—	$826,000	$5,000	$7,421,877
John Leite	Global Chief Commercial Officer	$510,300	—	$2,356,325	—	$331,185	$5,000	$3,202,810
Rebecca Chambers	Chief Financial Officer	$550,000	—	$1,963,604	—	$356,950	$5,000	$2,875,554
Annie McGuire	General Counsel and Head of Market Access	$500,000	—	$1,963,604	—	$324,500	$5,000	$2,793,104
Phillip G. Febbo	Chief Scientific Officer and Chief Medical Officer	$561,000	—	$1,570,883	—	$364,089	$5,000	$2,500,972

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marc Stapley	Chief Executive Officer	$675,000	—	$5,125,868	—	$1,012,500	$3,000	$6,816,368
Rebecca Chambers	Chief Financial Officer	$530,400	—	$2,674,366	—	$437,580	$3,000	$3,645,346
John Leite	Global Chief Commercial Officer	$472,500	—	$2,228,638	—	$389,813	$3,000	$3,093,951
Annie McGuire	General Counsel and Chief People Officer	$470,800	—	$2,228,638	—	$388,410	$3,000	$3,090,848
Phillip G. Febbo	Chief Scientific and Chief Medical Officer	$550,000	—	$1,782,911	—	$453,750	$3,000	$2,789,661

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marc Stapley	Chief Executive Officer	$650,000	—	$3,703,968	$1,927,416	$900,250	$3,000	$7,184,634
Phillip G. Febbo	Chief Scientific and Chief Medical Officer	$137,500	—	$2,335,753	$1,206,047	$104,741	$3,000	$3,787,041
Rebecca Chambers	Chief Financial Officer	$510,000	—	$1,234,624	$642,467	$388,493	$3,000	$2,778,584
Annie McGuire	General Counsel and Chief People Officer	$440,000	—	$1,111,181	$578,214	$335,170	$16,553	$2,481,118
John Leite	Global Chief Commercial Officer	$421,067	—	$858,051	$377,918	$264,433	$3,000	$1,924,469

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marc Stapley	Chief Executive Officer	$625,000	—	$2,206,626	$1,475,796	$625,000	$3,000	$4,935,422
Tina Nova	—	$500,000	—	$2,206,990	$1,476,039	$412,500	$3,000	$4,598,529
Giulia Kennedy	Former Global Chief Scientific and Chief Medical Officer	$500,000	—	$1,953,926	$1,408,639	—	$670,998	$4,533,563
Rebecca Chambers	Chief Financial Officer	$463,500	—	$1,406,185	$1,144,161	$305,910	$3,000	$3,322,756
Annie McGuire	General Counsel and Chief People Officer	$334,872	—	$933,955	$946,422	$154,041	$77,765	$2,447,055

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marc Stapley	Chief Executive Officer	$350,000	—	$2,569,723	$2,521,717	$297,500	$3,000	$5,741,940
Bonnie Anderson	Co-Founder and Executive Chair	$650,000	—	$2,161,225	$1,151,368	$552,500	$3,000	$4,518,093
Rebecca Chambers	Chief Financial Officer	$204,807	$100,000	$1,741,684	$1,237,510	$95,036	$3,000	$3,382,037
Keith Kennedy	Chief Operating Officer and Chief Financial Officer The amounts in this column represent bonuses awarded at the discretion of our Board of Directors above the amounts earned by meeting the performance measures established under our 2021 Bonus Plan. For more information see "—Compensation Discussion and Analysis-2021 Bonus Plan Awards." Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2021. There can be no assurance that option awards will be exercised or that RSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target. Other income includes matching contributions to 401(k) plans in an amount up to 3,000 per year for 2021 and 2,000 per year for 2020 and 2019. Other income for Ms. Chambers includes a sign-on bonus of 100,000. Other compensation includes severance and COBRA payments in the amount of 238,500. Other income for Mr. Kennedy also includes assistance with travel and living expenses associated with his commuting to our executive offices in South San Francisco, California as described in footnote below. Pursuant to the terms of his employment agreement, Mr. Kennedy was entitled to travel and living expense assistance in connection with his commuting to our executive offices in South San Francisco, California. In 2020 and 2019, these amounts totaled 146,357 and, 185,466, respectively, for reimbursed expenses for airline travel, parking, transportation and related travel incidentals, and living expense and tax gross-up paid for such expenses. Mr. Kennedy retired from our company, effective May 15, 2021.	$178,875	—	$1,370,913	$863,526	—	$241,500	$2,654,814
Giulia Kennedy	Former Global Chief Scientific and Chief Medical Officer	$469,050	—	$1,225,763	$719,605	$219,281	$3,000	$2,636,699
Jane Alley	Vice President, Accounting	$300,514	—	$730,990	$159,212	$94,500	$3,000	$1,288,216
James Erlinger III	Former Executive Vice President and General Counsel	$236,833	—	$435,450	$431,763	—	$111,707	$1,215,753

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bonnie Anderson	Co-Founder and Executive Chair	$625,000	—	$864,419	$2,454,926	$625,000	$2,000	$4,571,345
James Erlinger III	Former Executive Vice President and General Counsel	$400,000	—	—	$2,623,425	$95,000	—	$3,118,425
Keith Kennedy	Chief Operating Officer and Chief Financial Officer The amounts in this column represent bonuses awarded at the discretion of our Board of Directors above the amounts earned by meeting the performance measures established under our 2021 Bonus Plan. For more information see "—Compensation Discussion and Analysis-2021 Bonus Plan Awards." Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2021. There can be no assurance that option awards will be exercised or that RSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target. Other income includes matching contributions to 401(k) plans in an amount up to 3,000 per year for 2021 and 2,000 per year for 2020 and 2019. Other income for Ms. Chambers includes a sign-on bonus of 100,000. Other compensation includes severance and COBRA payments in the amount of 238,500. Other income for Mr. Kennedy also includes assistance with travel and living expenses associated with his commuting to our executive offices in South San Francisco, California as described in footnote below. Pursuant to the terms of his employment agreement, Mr. Kennedy was entitled to travel and living expense assistance in connection with his commuting to our executive offices in South San Francisco, California. In 2020 and 2019, these amounts totaled 146,357 and, 185,466, respectively, for reimbursed expenses for airline travel, parking, transportation and related travel incidentals, and living expense and tax gross-up paid for such expenses. Mr. Kennedy retired from our company, effective May 15, 2021.	$450,000	$12,500	$304,245	$863,315	$247,500	$148,357	$2,025,917
Giulia Kennedy	Former Global Chief Scientific and Chief Medical Officer	$451,000	$1,950	$304,245	$863,315	$248,050	$2,000	$1,870,560
John Hanna	Chief Commercial Officer	$395,000	$7,750	—	$860,537	$217,250	$2,000	$1,785,853

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bonnie Anderson	Co-Founder and Executive Chair	$580,000	$75,400	$606,300	$2,393,663	$504,600	$2,000	$4,161,963
Keith Kennedy	Chief Operating Officer and Chief Financial Officer The amounts in this column represent bonuses awarded at the discretion of our Board of Directors above the amounts earned by meeting the performance measures established under our 2021 Bonus Plan. For more information see "—Compensation Discussion and Analysis-2021 Bonus Plan Awards." Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2021. There can be no assurance that option awards will be exercised or that RSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target. Other income includes matching contributions to 401(k) plans in an amount up to 3,000 per year for 2021 and 2,000 per year for 2020 and 2019. Other income for Ms. Chambers includes a sign-on bonus of 100,000. Other compensation includes severance and COBRA payments in the amount of 238,500. Other income for Mr. Kennedy also includes assistance with travel and living expenses associated with his commuting to our executive offices in South San Francisco, California as described in footnote below. Pursuant to the terms of his employment agreement, Mr. Kennedy was entitled to travel and living expense assistance in connection with his commuting to our executive offices in South San Francisco, California. In 2020 and 2019, these amounts totaled 146,357 and, 185,466, respectively, for reimbursed expenses for airline travel, parking, transportation and related travel incidentals, and living expense and tax gross-up paid for such expenses. Mr. Kennedy retired from our company, effective May 15, 2021.	$432,000	$32,175	$1,268,400	$638,310	$215,325	$187,466	$2,773,676
Giulia Kennedy	Global Chief Scientific and Chief Medical Officer	$421,000	$33,107	$808,400	$638,310	$221,593	$2,000	$2,124,410
John Hanna	Chief Commercial Officer	$375,000	$26,862	—	$638,310	$179,438	$2,000	$2,030,010
Christopher Hall	The amounts in this column represent bonuses awarded at the discretion of our board of directors above the amounts earned by meeting the performance measures established under our 2019 Bonus Plan. For more information see"-Compensation Discussion and Analysis-2019 Bonus Plan Awards.". Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. There can be no assurance that option awards will be exercised or that RSUs or PSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs or PSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target, which was the probable outcome of the performance conditions as of December 31, 2018. The PSUs do not have staggered levels of achievement. Other income includes matching contributions to 401(k) plans in an amount up to 2,000 per year. Other income for Mr. Kennedy also includes assistance with travel and living expenses associated with his commuting to our executive offices in South San Francisco, California as described in footnote below. Pursuant to the terms of his employment agreement, Mr. Kennedy is entitled to travel and living expense assistance in connection with his commuting to our executive offices in South San Francisco, California. In 2019, 2018 and 2017, these amounts totaled 185,466, 200,899 and 197,709, respectively, for reimbursed expenses for airline travel, parking, transportation and related travel incidentals, and living expense and tax gross-up paid for such expenses.	$209,096	—	—	—	—	$491,578	$700,674

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bonnie Anderson	Chairman and Chief Executive Officer	$550,000	—	$897,000	$688,590	$514,250	$2,000	$2,831,240
Christopher Hall	The amounts in this column represent bonuses awarded at the discretion of our board of directors above the amounts earned by meeting the performance measures established under our 2019 Bonus Plan. For more information see"-Compensation Discussion and Analysis-2019 Bonus Plan Awards.". Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. There can be no assurance that option awards will be exercised or that RSUs or PSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs or PSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target, which was the probable outcome of the performance conditions as of December 31, 2018. The PSUs do not have staggered levels of achievement. Other income includes matching contributions to 401(k) plans in an amount up to 2,000 per year. Other income for Mr. Kennedy also includes assistance with travel and living expenses associated with his commuting to our executive offices in South San Francisco, California as described in footnote below. Pursuant to the terms of his employment agreement, Mr. Kennedy is entitled to travel and living expense assistance in connection with his commuting to our executive offices in South San Francisco, California. In 2019, 2018 and 2017, these amounts totaled 185,466, 200,899 and 197,709, respectively, for reimbursed expenses for airline travel, parking, transportation and related travel incidentals, and living expense and tax gross-up paid for such expenses.	$415,000	—	$448,500	$337,409	$287,600	$2,000	$1,578,415
Keith Kennedy	Chief Operating Officer and Chief Financial Officer	$400,000	—	$299,000	$236,416	$266,200	$202,899	$1,466,109

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bonnie Anderson	Chairman and Chief Executive Officer	$550,000	—	—	$1,441,128	$220,000	$2,000	$2,213,128
Christopher Hall	The amounts in this column represent bonuses awarded at the discretion of our board of directors above the amounts earned by meeting the performance measures established under our 2019 Bonus Plan. For more information see"-Compensation Discussion and Analysis-2019 Bonus Plan Awards.". Amounts represent the aggregate fair value of the awards computed as of the grant date of each award in accordance with Topic 718 for financial reporting purposes, rather than amounts paid to or realized by the named individual. Our assumptions with respect to the calculation of these values are set forth in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. There can be no assurance that option awards will be exercised or that RSUs or PSUs will settle (in which case no value will be realized by the individual) or that the value on exercise of options or settlement of RSUs or PSUs will approximate the fair value as computed in accordance with Topic 718. We computed the grant date fair value of PSU awards based on our achievement of the PSU awards' performance conditions at 100% of target, which was the probable outcome of the performance conditions as of December 31, 2018. The PSUs do not have staggered levels of achievement. Other income includes matching contributions to 401(k) plans in an amount up to 2,000 per year. Other income for Mr. Kennedy also includes assistance with travel and living expenses associated with his commuting to our executive offices in South San Francisco, California as described in footnote below. Pursuant to the terms of his employment agreement, Mr. Kennedy is entitled to travel and living expense assistance in connection with his commuting to our executive offices in South San Francisco, California. In 2019, 2018 and 2017, these amounts totaled 185,466, 200,899 and 197,709, respectively, for reimbursed expenses for airline travel, parking, transportation and related travel incidentals, and living expense and tax gross-up paid for such expenses.	$415,000	—	—	$371,904	$114,100	$2,000	$1,084,004
Keith Kennedy	Chief Operating Officer, Chief Financial Officer and Secretary	$400,000	—	—	$92,976	$100,000	$199,709	$792,685

Executive changes

Person	Role	Change	Effective	Filed
Marc Stapley	director	Appointed	2026-06-10	2026-06-11
Brent Shafer	director	Appointed	2026-06-10	2026-06-11
Evan Jones	director	Appointed	2026-06-10	2026-06-11
Tom Miller	director	Appointed	2026-06-10	2026-06-11
Karin Eastham	director	Appointed	2026-06-10	2026-06-11
Robert S. Epstein	director	Appointed	2026-06-10	2026-06-11
Jens Holstein	director	Appointed	2026-06-10	2026-06-11
Muna Bhanji	director	Appointed	2026-06-10	2026-06-11
Eliav Barr	director	Appointed	2026-06-10	2026-06-11
Dr. Kevin Haas	Chief Development and Technology Officer	Appointed	2026-03-24	2026-03-16
Marc Stapley	director	Appointed	2025-06-17	2025-06-18
Brent Shafer	director	Appointed	2025-06-17	2025-06-18
Jens Holstein	director	Appointed	2025-06-17	2025-06-18
Tom Miller	director	Appointed	2025-06-17	2025-06-18
Karin Eastham	director	Appointed	2025-06-17	2025-06-18
Muna Bhanji	director	Appointed	2025-06-17	2025-06-18
Eliav Barr	director	Appointed	2025-06-17	2025-06-18
Brent Shafer	directors of the Company	Appointed	2024-09-03	2024-09-04
Tom Miller, Ph.D.	directors of the Company	Appointed	2024-09-03	2024-09-04

Key facts CIK 1384101 CUSIP 92337F107 13F (30d) 87 filings 87 filers Visit website Investor relations